It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The FDA-approved version of semaglutide includes specific components ... Clinical trials on Ozempic and Wegovy have found ...

“It is FDA-approved for people with type 2 diabetes and is typically ... Metformin is not currently approved by the Food and ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Allurion Technologies Inc (ALUR) reports significant growth in recurring revenue and strategic restructuring, despite facing market headwinds and product recalls.

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Thank you for standing by. My name is John, and I’ll be your conference operator today. At this time I would like to welcome everyone to the Allurion Third Quarter Earnings Call. All lines have been ...

Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...

In today’s fast-paced world, weight management is often an uphill battle. With countless products flooding the market ...